136 related articles for article (PubMed ID: 34483284)
21. Prevention strategies for chemotherapy-induced hand-foot syndrome: a systematic review and meta-analysis of prospective randomised trials.
Macedo LT; Lima JP; dos Santos LV; Sasse AD
Support Care Cancer; 2014 Jun; 22(6):1585-93. PubMed ID: 24463616
[TBL] [Abstract][Full Text] [Related]
22. Self-identification and management of hand-foot syndrome (HFS): effect of a structured teaching program on patients receiving capecitabine-based chemotherapy for colon cancer.
Murugan K; Ostwal V; Carvalho MD; D'souza A; Achrekar MS; Govindarajan S; Gupta S
Support Care Cancer; 2016 Jun; 24(6):2575-81. PubMed ID: 26715292
[TBL] [Abstract][Full Text] [Related]
23. Integrative Herbal Medicine for Chemotherapy-Induced Peripheral Neuropathy and Hand-Foot Syndrome in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Liu Y; May BH; Zhang AL; Guo X; Lu C; Xue CC; Zhang H
Integr Cancer Ther; 2019; 18():1534735418817833. PubMed ID: 30526124
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of oral administration of cystine and theanine in colorectal cancer patients undergoing capecitabine-based adjuvant chemotherapy after surgery: a multi-institutional, randomized, double-blinded, placebo-controlled, phase II trial (JORTC-CAM03).
Hamaguchi R; Tsuchiya T; Miyata G; Sato T; Takahashi K; Miura K; Oshio H; Ohori H; Ariyoshi K; Oyamada S; Iwase S
Support Care Cancer; 2020 Aug; 28(8):3649-3657. PubMed ID: 31811480
[TBL] [Abstract][Full Text] [Related]
25. Topical non-occlusive polymers in hand-foot syndrome.
Fabbrocini G; Cristaudo A; Ionescu MA; Panariello L; Robert G; Pellicano M; Ayala F
G Ital Dermatol Venereol; 2018 Apr; 153(2):165-171. PubMed ID: 29564873
[TBL] [Abstract][Full Text] [Related]
26. [Assessment of hand-foot syndrome in cancer patients treated with capecitabine-containing chemotherapy].
Yamagiwa K; Shigematsu T; Takeda K; Shirai M; Amemori K; Sunda K; Koike C; Yamada T
Gan To Kagaku Ryoho; 2013 Dec; 40 Suppl 2():161-3. PubMed ID: 24712132
[TBL] [Abstract][Full Text] [Related]
27. Risk Factors of Capecitabine-Induced Hand-Foot Syndrome: A Single-Institution, Retrospective Study.
Kanbayashi Y; Taguchi T; Ishikawa T; Otsuji E; Takayama K
Oncology; 2023; 101(7):407-414. PubMed ID: 37075722
[TBL] [Abstract][Full Text] [Related]
28. Compliance and effective management of the hand-foot syndrome in colon cancer patients receiving capecitabine as adjuvant chemotherapy.
Son HS; Lee WY; Lee WS; Yun SH; Chun HK
Yonsei Med J; 2009 Dec; 50(6):796-802. PubMed ID: 20046420
[TBL] [Abstract][Full Text] [Related]
29. Pharmaceutical and clinical studies of celecoxib topical hydrogel for management of chemotherapy-induced hand-foot syndrome.
Shayeganmehr D; Ramezannia F; Gharib B; Rezaeilaal A; Shahi F; Jafariazar Z; Afshar M
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1571-1581. PubMed ID: 36418469
[TBL] [Abstract][Full Text] [Related]
30. Herbal medicine for hand-foot syndrome induced by fluoropyrimidines: A systematic review and meta-analysis.
Deng B; Sun W
Phytother Res; 2018 Jul; 32(7):1211-1228. PubMed ID: 29682836
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic Effect of Anti-Inflammatory Tripeptide Cream in Hand-Foot Syndrome/Skin Reaction Related to Anticancer Drugs: a Randomized, Double-Blind, Placebo-Controlled Pilot Trial.
Yang Y; Hahn JH; Kim MS; Jo M; Lee YP; Kim H; Kim HK; Kwon J; Lee KH; Han HS
Cancer Res Treat; 2024 Jun; ():. PubMed ID: 38853540
[TBL] [Abstract][Full Text] [Related]
32. Proton Pump Inhibitors Ameliorate Capecitabine-induced Hand-Foot Syndrome in Patients With Breast Cancer: A Retrospective Study.
Takemura M; Ikemura K; Yoshinami T; Toyozumi Y; Shintani T; Ueda M; Shimazu K; Okuda M
Anticancer Res; 2022 May; 42(5):2591-2598. PubMed ID: 35489750
[TBL] [Abstract][Full Text] [Related]
33. SNPs in the COX-2/PGES/EP signaling pathway are associated with risk of severe capecitabine-induced hand-foot syndrome.
Liao X; Huang L; Yu Q; He S; Li Q; Huang C; Yuan X
Cancer Chemother Pharmacol; 2020 Apr; 85(4):785-792. PubMed ID: 32193619
[TBL] [Abstract][Full Text] [Related]
34. Hand-foot syndrome and its impact on daily activities in breast cancer patients receiving docetaxel-based chemotherapy.
Hsu YH; Shen WC; Wang CH; Lin YF; Chen SC
Eur J Oncol Nurs; 2019 Dec; 43():101670. PubMed ID: 31586645
[TBL] [Abstract][Full Text] [Related]
35. Hand-foot syndrome induced by chemotherapy drug: Case series study and literature review.
Zaiem A; Hammamia SB; Aouinti I; Charfi O; Ladhari W; Kastalli S; Aidli SE; Lakhoua G
Indian J Pharmacol; 2022; 54(3):208-215. PubMed ID: 35848692
[TBL] [Abstract][Full Text] [Related]
36. Effect of a Novel Soaking Solution Used in Patients With Hand-Foot Syndrome as a Result of Capecitabine Treatment: A Randomized and Self-Controlled Trial.
Xie Y; Wang Q; Hu T; Chen R; Wang J; Chang H; Peng X; Cheng J
Clin Breast Cancer; 2022 Jul; 22(5):e685-e690. PubMed ID: 35354530
[TBL] [Abstract][Full Text] [Related]
37. Incidence and self-management of hand-foot syndrome in patients with colorectal cancer.
Zhao Y; Ding Y; Lu Y; Zhang J; Gu J; Li M
Clin J Oncol Nurs; 2013 Aug; 17(4):434-7. PubMed ID: 23899983
[TBL] [Abstract][Full Text] [Related]
38. The effect of TJ-28 (Eppikajutsuto) on the prevention of hand-foot syndrome using Capecitabine for colorectal cancer: The Yokohama Clinical Oncology Group Study (YCOG1102).
Watanabe K; Ishibe A; Watanabe J; Ota M; Fujii S; Ichikawa Y; Oba MS; Endo I
Indian J Gastroenterol; 2020 Apr; 39(2):204-210. PubMed ID: 32406009
[TBL] [Abstract][Full Text] [Related]
39. Incidence and implications of chemotherapy related hand-foot syndrome.
Nikolaou V; Syrigos K; Saif MW
Expert Opin Drug Saf; 2016 Dec; 15(12):1625-1633. PubMed ID: 27718746
[TBL] [Abstract][Full Text] [Related]
40. Hand-foot syndrome due to sorafenib in hepatocellular carcinoma treated with vitamin E without dose modification; a preliminary clinical study.
Bozkurt Duman B; Kara B; Oguz Kara I; Demiryurek H; Aksungur E
J BUON; 2011; 16(4):759-64. PubMed ID: 22331734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
